MetaADEDB 2.0 @ LMMD
Meclizine
(KDLHYOMCWBWLMM-UHFFFAOYSA-N)
Structure
SMILES
Clc1ccc(cc1)C(c1ccccc1)N1CCN(CC1)Cc1cccc(c1)C.O.Cl.Cl
Molecular Formula:
C25H31Cl3N2O
Molecular Weight:
481.885
Log P:
6.9711
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
3
TPSA:
15.71
CAS Number(s):
31884-77-2
Synonym(s)
1.
Meclizine
2.
Histametizyn
3.
Meclozine
4.
Parachloramine
5.
Agyrax
6.
Antivert
7.
Bonamine
8.
Bonine
9.
Chiclida
10.
D-Vert
11.
Meclizine Dihydrochloride
12.
Meclizine Hydrochloride
13.
Meclizine Monohydrochloride
14.
Ru-Vert-M
15.
D Vert
16.
DVert
17.
Dihydrochloride, Meclizine
18.
Hydrochloride, Meclizine
19.
Monohydrochloride, Meclizine
20.
Ru Vert M
External Link(s)
MeSHD008468
PubChem Compound91981561
173612
ChEBI31805
CHEMBLCHEMBL3989555
KEGGdr:D01317
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 76US FAERS
2DizzinessFAERS: 16US FAERS
3HypersensitivityFAERS: 8US FAERS
4Drug exposure during pregnancyFAERS: 7US FAERS
5HeadacheFAERS: 7US FAERS
6MalaiseFAERS: 5US FAERS
7VertigoFAERS: 5US FAERS
8Product substitution issueFAERS: 4US FAERS
9Abdominal discomfortFAERS: 3US FAERS
10Feeling abnormalFAERS: 3US FAERS
11NauseaFAERS: 3US FAERS
12PalpitationsFAERS: 3US FAERS
13AngioedemaFAERS: 2US FAERS
14AstheniaFAERS: 2US FAERS
15Cerebrovascular accidentFAERS: 2US FAERS
16FatigueFAERS: 2US FAERS
17Pharmaceutical product complaintFAERS: 2US FAERS
18Product use issueFAERS: 2US FAERS
19AneurysmFAERS: 1US FAERS
20Atrial FibrillationFAERS: 1US FAERS
21AuraFAERS: 1US FAERS
22CheilitisFAERS: 1US FAERS
23Creutzfeldt-Jakob diseaseFAERS: 1US FAERS
24Drug effect delayedFAERS: 1US FAERS
25Drug effect incompleteFAERS: 1US FAERS
26DysarthriaFAERS: 1US FAERS
27Impaired driving abilityFAERS: 1US FAERS
28Inappropriate affectFAERS: 1US FAERS
29Inappropriate schedule of drug administrationFAERS: 1US FAERS
30Intentional drug misuseFAERS: 1US FAERS
31LethargyFAERS: 1US FAERS
32Low set earsFAERS: 1US FAERS
33MalabsorptionFAERS: 1US FAERS
34Memory impairmentFAERS: 1US FAERS
35Neck PainFAERS: 1US FAERS
36PainFAERS: 1US FAERS
37PresyncopeFAERS: 1US FAERS
38PruritusFAERS: 1US FAERS
39Reaction to excipientFAERS: 1US FAERS
40RetrognathiaFAERS: 1US FAERS
41SomnolenceFAERS: 1US FAERS
42Therapeutic response unexpectedFAERS: 1US FAERS
43Urinary tract infectionFAERS: 1US FAERS
44UrticariaFAERS: 1US FAERS
45VomitingFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.